The Impact of Statin Therapy in the Covid-19 Patients

NCT05238402 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 707

Last updated 2022-02-14

No results posted yet for this study

Summary

In the retrospective case series, consecutive COVID-19 patients admitted from June 1 to December 31, 2020, were analyzed. A 1:1 matched cohort was created by propensity score-matched analysis. Demographic data, laboratory findings, comorbidities, treatments, and in-hospital outcomes were collected and compared between COVID-19 patients with and without statin use.

Conditions

Interventions

DRUG

Statin

Statin on COVID 19 patienst

Sponsors & Collaborators

  • Antalya Training and Research Hospital

    lead OTHER_GOV

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2020-12-31
Completion
2021-03-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05238402 on ClinicalTrials.gov